Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Chen

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Clinical Cardiology|May 15, 2020
Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE studyPaolo Colonna, Christian von Heymann, Amparo Santamaria, et al.
The American Journal of Cardiology|January 1, 2026
Patient-Reported Outcomes Using Win Ratio Analysis: A Post Hoc Analysis From The Randomized ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
Thrombosis Journal|December 15, 2023
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE studyChristian von Heymann, Martin Unverdorben, Paolo Colonna, et al.
Journal of Clinical Medicine|February 6, 2021
Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF ProgramRaffaele De Caterina, Young-Hoon Kim, Yukihiro Koretsune, et al.
The Journal of Urology|February 8, 2002
Long-term followup after laparoscopic radical nephrectomyAndrew J Portis, Yan Yan, Jaime Landman, et al.
Journal of Endourology|September 23, 2011
Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University updateMichael W Gardner, Timur M Roytman, Cathy Chen, et al.
The American Journal of Cardiology|December 17, 2025
Comparative Performance of Machine Learning and Traditional Risk Scores in Predicting Adverse Events After Transcatheter Aortic Valve Replacement in Patients With Atrial FibrillationJohny Nicolas, George Dangas, Amanda Borrow, et al.
The American Journal of Cardiology|October 17, 2023
Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
Journal of the Chinese Medical Association : JCMA|March 20, 2021
Factors associated with the dosing of edoxaban for stroke prevention in patients with atrial fibrillation from South Korea and Taiwan: 1-year data from the Global ETNA-AF ProgramTze-Fan Chao, Keun-Sik Hong, Byung-Chul Lee, et al.
The Journal of Urology|March 17, 2004
Prospective comparison of the immunological and stress response following laparoscopic and open surgery for localized renal cell carcinomaJaime Landman, Ephrem Olweny, Chandru P Sundaram, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Clinical Cardiology|May 15, 2020
Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE studyPaolo Colonna, Christian von Heymann, Amparo Santamaria, et al.
The American Journal of Cardiology|January 1, 2026
Patient-Reported Outcomes Using Win Ratio Analysis: A Post Hoc Analysis From The Randomized ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
Thrombosis Journal|December 15, 2023
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE studyChristian von Heymann, Martin Unverdorben, Paolo Colonna, et al.
Journal of Clinical Medicine|February 6, 2021
Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF ProgramRaffaele De Caterina, Young-Hoon Kim, Yukihiro Koretsune, et al.
The Journal of Urology|February 8, 2002
Long-term followup after laparoscopic radical nephrectomyAndrew J Portis, Yan Yan, Jaime Landman, et al.
Journal of Endourology|September 23, 2011
Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University updateMichael W Gardner, Timur M Roytman, Cathy Chen, et al.
The American Journal of Cardiology|December 17, 2025
Comparative Performance of Machine Learning and Traditional Risk Scores in Predicting Adverse Events After Transcatheter Aortic Valve Replacement in Patients With Atrial FibrillationJohny Nicolas, George Dangas, Amanda Borrow, et al.
The American Journal of Cardiology|October 17, 2023
Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
Journal of the Chinese Medical Association : JCMA|March 20, 2021
Factors associated with the dosing of edoxaban for stroke prevention in patients with atrial fibrillation from South Korea and Taiwan: 1-year data from the Global ETNA-AF ProgramTze-Fan Chao, Keun-Sik Hong, Byung-Chul Lee, et al.
The Journal of Urology|March 17, 2004
Prospective comparison of the immunological and stress response following laparoscopic and open surgery for localized renal cell carcinomaJaime Landman, Ephrem Olweny, Chandru P Sundaram, et al.
Pageof 7